Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore
Emcure Pharmaceuticals moved higher in a quarterly results development for Q2 FY27.
· Economic Times Markets, ET Stocks, BS Companies
Emcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore. Revenue grew 24.3%, while EBITDA rose 30.9%, supported by strong international business growth.
Key facts
- Period
- Q2 FY27
The analysis
Emcure Pharmaceuticals reported Rs 325 crore for Q2 FY27, with movement of 7%, 29% and 7.3% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +4.9% on the day at ₹1,976.60, and has returned +0.3% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -0.8% over the same period, so Emcure Pharmaceuticals is running 1.1 points ahead of its peers.
For Emcure Pharmaceuticals, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Emcure Pharmaceuticals (EMCURE), in Pharma & Healthcare.
- Over three months: Emcure Pharmaceuticals +0.3% against Pharma & Healthcare -0.8% (1.1 points ahead).
- Trading well above normal today: Emcure Pharmaceuticals at 6.8 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Emcure PharmaceuticalsEMCURE · Pharma & Healthcare | ₹1,976.60 | +4.9% | +1.6% | +0.3% | -1.6% | 6.8× | — |
Pharma & Healthcare
1M +0.9% · 3M -0.8%
Emcure Pharmaceuticals
Prices as of 3 Nov 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Pfizer's One-Time Gain Lifts Profit; SBI Asset Quality Improves; Solar Industries Profit Zooms 79%
Q2 Results Live: Zydus Wellness Swings To Profit; SBI, NSE Earnings In Focus
Stocks to watch: ITC, Lupin, NBCC, SBI, Dr Reddy's, Bosch, Ola Electric
Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma
Why is market rallying today? Sensex soars over 950 pts, Nifty tops 23,300. 7 factors driving Rs 4 lakh crore D-Street gains